Cipher Pharmaceuticals Inc. (CPHRF) Financials

CPHRF Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 153.8 million 20.6 million
Dec. 31, 2025 156.2 million 30.2 million
Sept. 30, 2025 147.5 million 33.6 million
June 30, 2025 152.4 million 43.0 million

CPHRF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 4.5 million ?
Dec. 31, 2025 8.8 million ?
Sept. 30, 2025 10.7 million 533000
June 30, 2025 6.0 million 436000

CPHRF Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 6.1 million
Dec. 31, 2025 13.5 million
Sept. 30, 2025 5.5 million
June 30, 2025 5.9 million

CPHRF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 6.4 million - 165542
Dec. 31, 2025 7.5 million 5.0 million 215606
Sept. 30, 2025 8.4 million 13.0 million 393000
June 30, 2025 11.3 million 25.0 million 455000

CPHRF Shares Outstanding

No data available :(

CPHRF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 987 - 2.9 million -
Dec. 31, 2025 25433 - 4.0 million -
Sept. 30, 2025 81000 - 3.7 million 571000
June 30, 2025 34 - 4.1 million -

CPHRF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 12.3 million 4.0 million
Dec. 31, 2025 12.4 million 4.2 million
Sept. 30, 2025 12.8 million 2.3 million
June 30, 2025 13.4 million 2.5 million

CPHRF

Price: $11.70

52 week price:
8.64
15.00

Earnings Per Share: 0.67 USD

P/E Ratio: 16.42

Exchange: OQX

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 298.9 million

Links: